SRT 1720

CAS No.	925434-55-5	Cat. No.	BCP13176
Name	SRT 1720
Synonyms	SRT-1720;SRT1720; CAY10559; CAY-10559; CAY 10559; SIRT-1933; SIRT 1933; SIRT1933;
Formula	C25H23N7OS	M. Wt	469.57

Description	SRT-1720, also known as CAY10559 and is a drug developed by Sirtris Pharmaceuticals intended as a small-molecule activator of the sirtuin subtype SIRT1. It has similar activity in the body to the known SIRT1 activator resveratrol, but is 1000x more potent. In animal studies it was found to improve insulin sensitivity and lower plasma glucose levels in fat, muscle and liver tissue, and increased mitochondrial and metabolic function. A study of SRT1720 conducted by the National Institute on Aging found that the drug may extend the lifespan of obese mice by 44% .
Related Products	1001645-58-4（SRT 1720 Hydrochloride）
Pathways	Cell Cycle/DNA Damage Epigenetics
Targets	Sirtuin

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Products are for research use only and not for human use. We do not sell to patients.